Ana de Avelar MuracaDMF Analyst at Apsen FarmacĂȘutica, BrazilSpeaker
Agenda Sessions
A Strategy to Carry Out Risk Assessment of Mutagenic Impurities in the Industry, in Order to Avoid the Requirement of Regulatory Agencies
, 10:35amView Session